DELONG MARK JEFFREY (Senior Vice President) sold 0.3% of their position (368.00 shares) of APELLIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $8.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/13/2026ACC: 0001492422-26-000083
Officer· Senior Vice President
Since Mar 2021
-368.00
Net shares
Net seller
$8.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
368.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−368.00
Price / share
$22.15
Trade value
$8.15K
% of position
0.3%
2/11/2026
114.96K→114.59K
Total
Net shares
−368.00
Net value
-$8.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/11/2026 | S · Sale | −368.00 | $22.15 | $8.15K | 0.3% | 114.96K | 114.59K |
| Total | −368.00 | -$8.15K | ||||||
Derivative Transactions0
No derivative transactions reported